RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases

Journal of Gastrointestinal Surgery

Volumn 21, Issue 1, 2017, Pages 68-77

  Denbo, Jason W ^a   Yamashita, Suguru ^a   Passot, Guillaume ^a   Egger, Michael ^a   Chun, Yun S ^a   Kopetz, Scott E ^a   Maru, Dipen ^a   Brudvik, Kristoffer Watten ^a   Wei, Steven H ^a   Conrad, Claudius ^a   Vauthey, Jean Nicolas ^a   Aloia, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colorectal liver metastases; RAS mutation; Repeat hepatectomy; Survival

Indexed keywords

ADULT; AGED; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; FEMALE; GENETICS; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MUTATION; ONCOGENE RAS; PATHOLOGY; REOPERATION; SECONDARY; SURVIVAL ANALYSIS; TUMOR RECURRENCE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENES, RAS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; REOPERATION; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84975454707     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-016-3189-9     Document Type: Article

References (27)

1. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987, 327(6120):298-303.
2. Khosravi-Far R, Campbell S, Rossman KL, Der CJ: Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Advances in cancer research 1998, 72:57-107.
3. Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, D’Haens G, Pinter T, Lim R, Bodoky G et al: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. The New England journal of medicine 2009, 360(14):1408-1417.
4. Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM: RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Annals of surgery 2013, 258(4):619-626; discussion 626-617.
5. Mise Y, Zimmitti G, Shindoh J, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM et al: RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Annals of surgical oncology 2015, 22(3):834-842.
6. Brudvik KW, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, Conrad C, Maru DM, Aloia TA, Vauthey JN: RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Annals of surgical oncology 2016.
7. Karagkounis G, Torbenson MS, Daniel HD, Azad NS, Diaz LA, Jr., Donehower RC, Hirose K, Ahuja N, Pawlik TM, Choti MA: Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer 2013, 119(23):4137-4144.
8. Nash GM, Gimbel M, Shia J, Nathanson DR, Ndubuisi MI, Zeng ZS, Kemeny N, Paty PB: KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases. Annals of surgical oncology 2010, 17(2):572-578.
9. Schirripa M, Bergamo F, Cremolini C, Casagrande M, Lonardi S, Aprile G, Yang D, Marmorino F, Pasquini G, Sensi E et al: BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection. British journal of cancer 2015, 112(12):1921-1928.
10. Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ et al: Association between KRAS mutation and lung metastasis in advanced colorectal cancer. British journal of cancer 2015, 112(3):424-428.
11. Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN: Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. The British journal of surgery 2015, 102(10):1175-1183.
12. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Annals of surgery 2004, 239(6):818-825; discussion 825-817.
13. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Annals of surgery 2004, 240(3):438-447; discussion 447-450.
14. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM: Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Annals of surgery 2009, 250(3):440-448.
15. Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, Ono Y, Kokudo N: Favorable outcome after repeat resection for colorectal liver metastases. Annals of surgical oncology 2014, 21(13):4293-4299.
16. Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN: Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB: the official journal of the International Hepato Pancreato Biliary Association 2011, 13(11):774-782.
17. Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y: Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis Annals of surgery 2002, 235(6):863-871.
18. Battula N, Tsapralis D, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Bramhall S, Mirza D, Marudanayagam R: Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience. HPB: the official journal of the International Hepato Pancreato Biliary Association 2014, 16(2):157-163.
19. Aloia TA, Zorzi D, Abdalla EK, Vauthey JN: Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Annals of surgery 2005, 242(2):172-177.
20. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G et al: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Annals of surgery 2005, 241(5):715-722, discussion 722-714.
21. Blazer DG, 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H et al: Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008, 26(33):5344-5351.
22. Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN: Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. Journal of the American College of Surgeons 2016.
23. Kawamata H, Yamashita K, Kojo K, Ushiku H, Ooki A, Watanabe M: Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13. Genomics 2015, 106(2):71-75.
24. Luo LX, Yu ZY, Huang JW, Wu H: Selecting patients for a second hepatectomy for colorectal metastases: an systemic review and meta-analysis. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2014, 40(9):1036-1048.
25. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Annals of surgery 1999, 230(3):309-318; discussion 318-321.
26. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996, 77(7):1254-1262.
27. Hill CR, Chagpar RB, Callender GG, Brown RE, Gilbert JE, Martin RC, 2nd, McMasters KM, Scoggins CR: recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Annals of surgical oncology 2012, 19(1):139-144.